Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 April 2023 | Story André Damons
wada2 Web read more
Since 2014, in April of every year, the anti-doping community worldwide comes together to celebrate Play True Day – a day that is dedicated to Clean Sport and raising awareness among athletes, the sporting public and others, of the importance of preventing doping.

The South African Doping Control Laboratory (SADoCoL), a World Anti-Doping Agency (WADA)-accredited service laboratory on the Bloemfontein Campus of the University of the Free State (UFS), will take part in celebrating international Play True Day on 14 April.

SADoCoL is the only fully WADA-accredited laboratory that performs analysis for the anti-doping community in Africa. 

Every April since 2014  the anti-doping community worldwide comes together to celebrate Play True Day – a day that is dedicated to Clean Sport and raising awareness among athletes, the sporting public and others, of the importance of preventing doping.

Basis for the anti-doping community

Hanno du Preez, SADoCoL Director, says for SADoCoL, the celebration of the Play True Day supplies acknowledgement to the scientists who work around the clock to ensure the anti-doping campaigns, by various stakeholders on the continent, are supported by excellent scientific analysis and research.

“It is a privilege for SADoCoL to have been an active participant in the global anti-doping process for four decades. SADoCoL celebrates international Play True Day with its partners and stakeholders, including the host, the UFS, and is proud to be part of this system of excellence. 

“The possibility for SADoCoL to be housed by the UFS is an excellent gateway to ensure proper research is conducted and provides a basis where students are also trained in the application of scientific skills in a very specialised focus area such as anti-doping. Since the inception of the Play True campaign, it has grown to an international renowned celebration ensuring that anti-doping education is enhanced and the sharing of knowledge concerning prohibited substances and the illegal use of these performance-enhancing drugs in sport, is reiterated.”

The Play True campaign provides the basis for the anti-doping community to ensure that clean sport is commemorated and achieved and that the results of athlete participation are true and fair. Not only does this campaign ensure Clean Sport, but  also enhances the profile of a nation’s sporting community, when the athletes support the Clean Sport campaign and ensure that participation is fair and clean.

Commemorates efforts of the anti-doping partners

Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, says the university is celebrating with its partners in  international Play True Day. This day commemorates the efforts of the anti-doping partners globally to ensure that clean competition prevails in all sports. Further, it enhances the commitment of our athletes to the principle of Clean Sport by taking part in this campaign. 

“The celebration is of importance to the UFS as it houses one of 30 globally accredited laboratories conducting the testing of athlete samples. SADoCoL, housed on the main campus of the UFS, has been in existence for almost 40 years and the importance of this laboratory commemorates the work which the UFS conducts as part of this important campaign.

With several national and international athletes representing the UFS, it is an important part of the community engagement and service provided by the UFS through the services of SADoCoL. The continuous efforts by the scientists of SADoCoL provide the opportunity for South African and African athletes to compete in the international arena, with the knowledge that it is conducted with a clear conscience and true to the principles of Clean Sport,” says Prof Petersen. 

 

Be true to yourself and compete on your own merit

Louzanne Coetzee, a UFS athlete who won silver and bronze medals at the Paralympic Games in 2021, says an organisation like WADA is important as it reminds athletes of the value of clean and fair sport. 

“As athletes we should strive to win on merit and not through doping, which is  the same as cheating. Sometimes people  make use of banned substances to win competitions, and this is unfair towards clean athletes. Doping can demotivate clean athletes, because they know they do not stand a chance against thosewho dope. 
“On this day, Play True Day 2023, my message is to be true to yourself and to compete on your own merit. Know that when you stand on a podium it is because of your own abilities, not drugs you took that allowed you to get there.”

Become part of this campaign and pledge your participation in clean sport and fair play!
#PlayTrue
#PlayTrueDay 
#OnePlayTrueTeam 
#UFS

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept